Phreesia, Inc. (NYSE:PHR) Shares Bought by Vanguard Group Inc.

Vanguard Group Inc. increased its stake in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 1.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,823,110 shares of the company's stock after purchasing an additional 61,048 shares during the quarter. Vanguard Group Inc. owned 8.30% of Phreesia worth $121,349,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the stock. Franklin Resources Inc. boosted its holdings in shares of Phreesia by 3.0% in the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company's stock valued at $31,495,000 after buying an additional 42,973 shares in the last quarter. State Street Corp increased its position in Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company's stock valued at $30,256,000 after acquiring an additional 88,517 shares during the period. Geode Capital Management LLC raised its stake in Phreesia by 4.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company's stock valued at $28,397,000 after acquiring an additional 55,934 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in Phreesia by 10.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company's stock worth $12,415,000 after acquiring an additional 46,209 shares during the period. Finally, Peregrine Capital Management LLC grew its stake in shares of Phreesia by 0.8% in the 4th quarter. Peregrine Capital Management LLC now owns 319,327 shares of the company's stock valued at $8,034,000 after purchasing an additional 2,531 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on PHR shares. Canaccord Genuity Group lifted their price objective on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research report on Thursday, March 13th. Needham & Company LLC reiterated a "buy" rating and issued a $29.00 price target on shares of Phreesia in a report on Thursday, March 13th. KeyCorp boosted their price objective on shares of Phreesia from $28.00 to $30.00 and gave the stock an "overweight" rating in a research report on Wednesday, January 8th. Royal Bank of Canada raised Phreesia from a "sector perform" rating to an "outperform" rating and increased their price objective for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. Finally, Citigroup boosted their target price on shares of Phreesia from $31.00 to $35.00 and gave the company a "buy" rating in a research note on Friday, January 10th. Twelve investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus target price of $31.33.

Phreesia Trading Up 0.3 %

Shares of PHR traded up $0.06 during trading hours on Friday, hitting $24.06. The stock had a trading volume of 472,952 shares, compared to its average volume of 434,045. The company's fifty day simple moving average is $26.57 and its 200 day simple moving average is $24.27. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The firm has a market cap of $1.41 billion, a P/E ratio of -16.37 and a beta of 0.82.

Insider Activity

In related news, COO Evan Roberts sold 1,785 shares of the firm's stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $26.98, for a total transaction of $48,159.30. Following the sale, the chief operating officer now directly owns 768,208 shares in the company, valued at approximately $20,726,251.84. This trade represents a 0.23 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Amy Beth Vanduyn sold 4,720 shares of the company's stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $27.31, for a total value of $128,903.20. Following the completion of the transaction, the senior vice president now owns 110,309 shares of the company's stock, valued at approximately $3,012,538.79. This represents a 4.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 176,963 shares of company stock valued at $4,920,321 in the last three months. Corporate insiders own 5.80% of the company's stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.